What's New

Medical News
& Alerts

Conferences
& Meetings


Other Medical
Resources

Employment
Opportunities

Partnering
Opportunities

Search results for: EntreMed
96%DGNews: Thalidomide Clinical Trials Expanded
96%DGNews: Endostatin, Newly Discovered Angiogenic Inhibitor Licensed
95%DGNews: EntreMed's Thalidomide Analog Receives FDA Orphan Drug Designation for Multiple Myeloma
95%DGNews: FDA Grants Orphan Drug Status to Endostatin and Panzem for Neuroendocrine Tumors and Multiple Myeloma
94%DGNews: Positive Prostate Cancer Interim Results In Clinical Trials With Thalidomide
93%DGNews: EntreMed Granted Orphan Drug Designation for Panzem(R) (2ME2) In Glioblastoma
93%DGNews: FDA Grants Orphan Drug Status for Panzem (2ME2), Treatment for Ovarian Cancer
79%DGNews: AACR-EORTC-NCI: Endostatin, Angiostatin Well Tolerated by Cancer Patients
79%DGNews: AACR-EORTC-NCI: Angiostatin Plus Radiation Produces Durable Partial Response In Variety Of Cancers
Enter keywords you wish to find information about:

Search for documents that contain:
any of these words.
this exact phrase.
all of these words.

 

 

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.

All contents Copyright (c) 1998 PSL Consulting Group Inc.
all rights reserved.